Immuno-Oncology Research & Immunotherapies for Cancer Treatment
Immuno-oncology is a rapidly advancing field of cancer research that harnesses the body's immune system to recognize, target, and eliminate cancer cells. Researchers develop personalized cancer immunotherapies, including CAR T cell therapies and other engineered immune cell therapies, to overcome immune evasion and improve patient outcomes. STEMCELL Technologies supports discovery and therapeutic development with innovative research tools, high-quality primary cells, scientific resources, and technical expertise.
Explore educational resources, protocols, and research products across key areas of immuno-oncology, including engineered immune cell therapies, cancer biomarkers, preclinical cancer models, and more.
Production of Chimeric Antigen Receptor T Cells
This free Nature Protocols Wallchart summarizes the processes involved in producing CAR T cells for therapy.
Get Your Free Copy >
- Monoclonal antibody therapy for cancer
- Myeloid-derived suppressor cells
- Epigenetic landscape of B cells
- Use of genome editing on immune cells for clinical applications
- Dendritic cell therapy for cancer
- CD137 (4-1BB) immunotherapy
- Assay Development
- Immuno-Oncology Drug Development
